Reducible, dibromomaleimide-linked polymers for gene delivery
Source abstract
Abstract
Polycations have been successfully used as gene transfer vehicles both in vitro and in vivo; however, their cytotoxicity has been associated with increasing molecular weight. Polymers that can be rapidly degraded after internalization are typically better tolerated by mammalian cells compared to their non-degradable counterparts. Here, we report the use of a dibromomaleimide-alkyne (DBM-alkyne) linking agent to reversibly bridge cationic polymer segments for gene delivery and to provide site-specific functionalization by azide-alkyne cycloaddition chemistry. A panel of reducible and non-reducible, statistical copolymers of (2-dimethylamino)ethyl methacrylate (DMAEMA) and oligo(ethylene glycol)methyl ether methacrylate (OEGMA) were synthesized and evaluated. When complexed with plasmid DNA, the reducible and non-reducible polymers had comparable DNA condensation properties, sizes, and transfection efficiencies. When comparing cytotoxicity, the DBM-linked, reducible polymers were significantly less toxic than the non-reducible polymers. To demonstrate polymer functionalization by click chemistry, the DBM-linked polymers were tagged with an azide-fluorophore and were used to monitor cellular uptake. Overall, this polymer system introduces the use of a reversible linker, DBM-alkyne, to the area of gene delivery and allows for facile, orthogonal, and site-specific functionalization of gene delivery vehicles.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Virus-based gene therapy research · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
University of Washington
Department of Bioengineering and Molecular Engineering and Sciences Institute
Seattle
USA
Funding
National Institutes of Health
References (37)
Show source-provided references
1. Thomas · Nat. Rev. Genet. · 2003 · 4 · 34610.1038/nrg1066 ↗
2. Niidome · Gene Ther. · 2002 · 9 · 164710.1038/sj.gt.3301923 ↗
3. Pack · Nat. Rev. Drug Discovery · 2005 · 4 · 58110.1038/nrd1775 ↗
4. Abdallah · Hum. Gene Ther. · 1996 · 7 · 194710.1089/hum.1996.7.16-1947 ↗
5. Jäger · Chem. Soc. Rev. · 2012 · 41 · 475510.1039/c2cs35146c ↗
6. Al-Dosari · AAPS J. · 2009 · 11 · 67110.1208/s12248-009-9143-y ↗
7. Lv · J. Controlled Release · 2006 · 114 · 10010.1016/j.jconrel.2006.04.014 ↗
8. Fischer · Biomaterials · 2003 · 24 · 112110.1016/S0142-9612(02)00445-3 ↗
9. Schellinger · Biomaterials · 2013 · 34 · 231810.1016/j.biomaterials.2012.09.072 ↗
10. Chu · Biomaterials · 2013 · 34 · 963210.1016/j.biomaterials.2013.08.045 ↗
11. Wong · Bioconjugate Chem. · 2006 · 17 · 15210.1021/bc0501597 ↗
12. Erbacher · Pharm. Res. · 1998 · 15
13. Köping-Höggård · Gene Ther. · 2004 · 11 · 144110.1038/sj.gt.3302312 ↗
14. Wei · Biomacromolecules · 2013 · 14 · 27510.1021/bm301747r ↗
15. Chu · J. Controlled Release · 2012 · 157 · 44510.1016/j.jconrel.2011.10.016 ↗
16. Johnson · Biomacromolecules · 2010 · 300710.1021/bm100806h ↗
17. Rungsardthong · J. Controlled Release · 2001 · 73 · 35910.1016/S0168-3659(01)00295-4 ↗
18. Uzgün · Biomacromolecules · 2010 · 11 · 3910.1021/bm9008759 ↗
19. Deshpande · J. Controlled Release · 2004 · 97 · 14310.1016/j.jconrel.2004.02.019 ↗
20. You · J. Controlled Release · 2007 · 122 · 21710.1016/j.jconrel.2007.04.020 ↗
21. Zhang · Biomacromolecules · 2012 · 13 · 31310.1021/bm2015174 ↗
22. Gosselin · Bioconjugate Chem. · 2001 · 12 · 98910.1021/bc0100455 ↗
23. Christensen · Bioconjugate Chem. · 2006 · 17 · 123310.1021/bc0602026 ↗
24. Burke · Bioconjugate Chem. · 2010 · 21 · 14010.1021/bc9003662 ↗
25. Wei · J. Am. Chem. Soc. · 2012 · 134 · 1655410.1021/ja3085803 ↗
26. Peng · Bioconjugate Chem. · 2008 · 19 · 49910.1021/bc7003236 ↗
27. Smith · J. Am. Chem. Soc. · 2010 · 132 · 196010.1021/ja908610s ↗
28. Moody · ChemBioChem · 2012 · 13 · 3910.1002/cbic.201100603 ↗
29. Cui · Macromol. Chem. Phys. · 2013 · 214 · 47010.1002/macp.201200614 ↗
30. Jones · J. Am. Chem. Soc. · 2012 · 134 · 184710.1021/ja210335f ↗
31. van de Wetering · J. Controlled Release · 1998 · 53 · 14510.1016/S0168-3659(97)00248-4 ↗
32. Robin · J. Am. Chem. Soc. · 2013 · 135 · 287510.1021/ja3105494 ↗
33. Layman · Biomacromolecules · 2009 · 10 · 124410.1021/bm9000124 ↗
34. Ryan · Chem. Commun. · 2011 · 47 · 545210.1039/c1cc11114k ↗
35. Verbaan · J. Gene Med. · 2004 · 6 · 6410.1002/jgm.475 ↗
36. Venkataraman · Biomaterials · 2011 · 32 · 236910.1016/j.biomaterials.2010.11.070 ↗
37. Richard · J. Biol. Chem. · 2003 · 278 · 58510.1074/jbc.M209548200 ↗